# Altaire Pharmaceuticals, Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

> Inspection records and compliance data for Altaire Pharmaceuticals, Inc. in Aquebogue, New York. Access full analysis and detailed observations.

---

## Details

- Name: Altaire Pharmaceuticals, Inc.
- FEI Number: 1000119582
- City: Aquebogue
- State: New York
- Country Name: United States
- Address Line 1: 311 W Ln
- Zip Code: 11931
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1251507 - Altaire Pharmaceuticals, Inc. - 2024-10-21](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/52c9de95-f12f-4b35-af57-5eadb622e6a6) — source: FDA, date: October 21, 2024
- [FDA Inspection 1251507 - Altaire Pharmaceuticals, Inc. - 2024-10-21](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/b61fd512-2687-4ca8-8d73-1cfa85e5c680) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2024
- [483 - Altaire Pharmaceuticals, Inc. - 2022-02-11](https://www.globalkeysolutions.net/records/483/altaire-pharmaceuticals-inc/d46bc047-8578-43cb-be2b-15ad8354c610) — source: FDA, date: February 11, 2022
- [FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - 2022-02-11](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/05e433a1-838b-41ab-8c34-777aa069c24d) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2022
- [FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - 2022-02-11](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/0c20c70c-b178-4306-8b90-55ba5c3ee376) — classification: Official Action Indicated (OAI), source: FDA, date: February 11, 2022
- [483 - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.globalkeysolutions.net/records/483/altaire-pharmaceuticals-inc/17b1c45d-8f0f-4d45-b23c-7c3a31908c74) — source: FDA, date: April 19, 2019
- [WARNING_LETTER - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.globalkeysolutions.net/records/warning_letter/altaire-pharmaceuticals-inc/ee7eb9fc-d9b3-4f35-a5bd-d29200e5854a) — source: FDA, date: April 19, 2019
- [FDA Inspection 1089315 - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/8e903be8-7abd-43af-8de9-de234d782298) — classification: Official Action Indicated (OAI), source: FDA, date: April 19, 2019
- [FDA Inspection 1089315 - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/88456698-720e-4890-8fa6-8e45eb548627) — classification: Official Action Indicated (OAI), source: FDA, date: April 19, 2019
- [483 - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.globalkeysolutions.net/records/483/altaire-pharmaceuticals-inc/6f5a38e3-831e-43d0-8235-9fde10683ff0) — source: FDA, date: March 9, 2017
- [FDA Inspection 1005208 - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/85f1078c-78b3-495c-ade6-7b56943269de) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2017
- [FDA Inspection 1005208 - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/f51d435b-4a99-4725-821e-eb2163b6329a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2017
- [FDA Inspection 955795 - Altaire Pharmaceuticals, Inc. - 2015-12-15](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/bb5c5e4f-6149-4940-bfb6-f98124102afd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2015
- [FDA Inspection 955795 - Altaire Pharmaceuticals, Inc. - 2015-12-15](https://www.globalkeysolutions.net/records/fda_inspections/altaire-pharmaceuticals-inc/35e079eb-d625-4856-9de2-9a6dbe0707be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2015

## Related Companies

- [Anika Therapeutics, Inc.](https://www.globalkeysolutions.net/companies/anika-therapeutics-inc/3499e53d-9858-4f0d-b826-b4a4a05ac3e7)
- [Best Sanitizers Inc](https://www.globalkeysolutions.net/companies/best-sanitizers-inc/909061b5-e25d-44be-a943-42f8624f27d7)
- [GEO Specialty Chemicals, Inc.](https://www.globalkeysolutions.net/companies/geo-specialty-chemicals-inc/05f781e7-99ba-4f36-a5d7-76f1bced9d0a)
- [Niagara Pharmaceuticals Inc](https://www.globalkeysolutions.net/companies/niagara-pharmaceuticals-inc/86d1fc76-da98-4df3-bf23-bed8075fdd53)
- [Takeda Manufacturing Austria AG](https://www.globalkeysolutions.net/companies/takeda-manufacturing-austria-ag/539fa431-79de-4217-805e-0e32f74178e7)
- [Chemisphere Corporation](https://www.globalkeysolutions.net/companies/chemisphere-corporation/60ff2ab3-c198-4dea-ab82-539d7bf5fbc0)
- [RWM Technologies LLC](https://www.globalkeysolutions.net/companies/rwm-technologies-llc/5f51490f-9a91-4f68-bf3b-631b95ba8617)
- [American Distilling Inc.](https://www.globalkeysolutions.net/companies/american-distilling-inc/6e6d0aa9-6d92-4f66-8aab-06289ec70292)
- [Hisun Pharmaceutical Hangzhou Co., Ltd](https://www.globalkeysolutions.net/companies/hisun-pharmaceutical-hangzhou-co-ltd/08054db1-b8fe-4c18-8ee5-e6098cb2e427)
- [Chemdex Inc](https://www.globalkeysolutions.net/companies/chemdex-inc/5a2f062f-a976-4769-b7a8-2f6180d03833)

## Related Officers

- [Biotechnology Specialist at FDA](https://www.globalkeysolutions.net/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd)
- [Avital Shimanovich](https://www.globalkeysolutions.net/people/avital-shimanovich/1417ebb4-da3a-4672-91ff-19d88cc26e23)
- [Enjoy Panicker](https://www.globalkeysolutions.net/people/enjoy-panicker/5208edd9-2362-4bda-857a-f52ab428ea90)
- [District Director](https://www.globalkeysolutions.net/people/diana-amador-toro/66f3f6c5-4cfe-4f40-b4d4-d24ed4618e64)